| Name | Title | Contact Details |
|---|
Engineering next‑generation, brain‑penetrant cancer therapies.
Discovering new medicines by combining ultra throughput biochemistry and machine learning.
Ankyra is developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response.
Elucida Oncology, Inc., is a clinical development stage company based on proprietary ultra-small C-Dot technology to find, see and treat an array of solid tumor cancers. Developed and clinically translated by Memorial Sloan-Kettering Cancer Center and Cornell University, C-Dots have published human safety and tumor-specific clinical data. Elucida Oncology is currently progressing through a broad clinical trial program while continuing to drive a future portfolio through ongoing innovation.
HomeDNA, Inc. is a Keller, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.